Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR

By sjmartinez • February 1, 2024

Murugesan P, Zhang Y, Huang Y, Chengong Zong N, Youn JY, Chen W, Wang C, Loscalzo J, Cai H. Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR. Circ Res. 2024 Feb 1. doi: 10.1161/CIRCRESAHA.123.323090. Epub ahead of print. PMID: 38299369.

Tags: Cardiology/Epi, fibrinolytic agents, Hypertension, hypoxia, Publications, pulmonary, tetrahydrobiopterin, vasodilation

Related Posts

Heart Failure Quality of Care Among Asian Patients in the United States

Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]